bpc 157 sprouts BPC-157 Delayed BPC 157 Caps - 1000mcg,

However, the challenges for viral-mediated approaches are some of the largest in the clinical trial setting: the inflammatory response to viral particles, the tissue-unspecific uptake of the content, the lack of entry in target cells, oncogenic side effects, and the overall absence of effect in most clinical trials carried out are some of the aspects that make these types of approaches hard to implement [285,286,287,288]

via Medical News Today

[PubMed] Compound 3: BPC-157 Research Findings Cellular Tendon-fibroblast outgrowth, migration, and oxidative-stress survival in explant and in-vitro cultures

For most first-time users, topical at 1 to 2% delivers visible results without the regulatory complications around compounded injectables

NHMRC (National Health and Medical Research Council)